Carbazole-based stilbene derivatives were also docked with both cholinesterases, as well as the Aβ1-42 peptide, and displayed potential as a multitarget inhibitor for AD in a 2020 study by Patel et al. [200]. Here, BCHE is linked to Alzheimer disease.